← All indications
Stomach Diseases
Pathological processes involving the STOMACH.
Subtype terms (14)
More specific conditions that are subtypes of Stomach Diseases in the MeSH hierarchy.
- Achlorhydria
4 drugs approved
- Diverticulosis, Stomach
- Duodenogastric Reflux
- Gastric Antral Vascular Ectasia
4 drugs approved
- Gastric Dilatation
- Gastric Outlet Obstruction
- Gastritis
97 drugs (40 approved, 57 experimental)
- Gastroparesis
52 drugs (35 approved, 17 experimental)
- Peptic Ulcer
87 drugs (53 approved, 34 experimental)
- Postgastrectomy Syndromes
- Stomach Neoplasms
873 drugs (262 approved, 611 experimental)
- Stomach Rupture
- Stomach Volvulus
- Zollinger-Ellison Syndrome
15 drugs (12 approved, 3 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (27)
- metronidazole
- orlistat
- acetylcysteine
- procaine benzylpenicillin
- Bismuth Subcitrate Potassium
- ceftazidime
- liraglutide
- simethicone
- acetaminophen
- silver nitrate
- sulbactam
- pantoprazole
- glucose
- autologous microbiome
- triamcinolone
- clarithromycin
- domperidone
- misoprostol
- lansoprazole
- rebamipide
- sodium chloride
- methylnaltrexone
- esomeprazole
- codeine
- baclofen
- aceclofenac
- Eupatilin
Phase 3 trials (17)
Phase 2 trials (16)
Phase 1 trials (15)
Other trials (28)
- diclofenac
- propofol
- 99mtc-dtpa
- human fibrin
- palmitoylethanolamide
- ginger
- lactulose
- insulin human
- etomidate
- itropride
- olanzapine
- human milk
- caffeine
- propranolol
- bufadienolide
- rifaximin
- conjugated linoleic acid
- coffee
- homoeriodictyol sodium salt
- fentanyl
- oxygen
- homoeriodictyol
- paromomycin
- loperamide
- dextrose
- lactobacillus reuteri
- xiangsha liujunzi
- lemongrass oil
Organizations
Organization Involved with Phase 4 Indications (9)
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Other Experimental Indications (7)